TCR signal–enhancing mutation alters lipid metabolism of thymocytes and impairs antitumor immunity of mature T cells
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2507154122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Wenhua Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Children's Hospital, Shanghai Institute of Immunology, Department of…. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, Lipid Metabolism, Thymocytes, T-Lymphocytes. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Key Research and Development Program of China (NKPs), National natural science foundation of China.
Abstract (Originalsprache)
The T cell receptor (TCR), a master regulator of adaptive immunity, serves as a molecular transducer that converts antigen recognition into precisely modulated intracellular signals, orchestrating both T cell development and effector functions. In this study, we leveraged a germline CD3ε I173A mutation, a previously characterized alteration that amplifies TCR signaling through the disruption of inhibitory lipid interactions, to dissect how thymocyte-intrinsic TCR signaling amplification influences the fate of mature T cells. Remarkably, thymic double-positive cells in CD3ε I173A mice with altered TCR repertoires demonstrated a significant downregulation of the phosphatidylserine decarboxylase homolog gene AC149090.1 . This modulation triggered a comprehensive rewiring of lipid metabolic pathways, establishing a systemic compensatory mechanism to counterbalance excessive TCR signaling. These metabolic adaptations culminated in functionally compromised mature T cells, characterized by diminished activation potential, reduced proliferative capacity, and impaired antitumor efficacy in CD3ε I173A mice. Our results underscore the critical role of thymic TCR signaling in T cell development for sustaining immune homeostasis and orchestrating mature T cell functionality, unveiling the lipid metabolic plasticity during thymocyte development that acts as a critical regulatory checkpoint for maintaining immune homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Children's Hospital, Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of…
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
ORCID-Profile: Wenhua Liang, Feng Wang
Förderung
- MOST | National Key Research and Development Program of China (NKPs)
- National natural science foundation of China
Zitieren
APA
Liang, W., Liang, Y., Yu, M., Ji, C., & Wang, F. (2025). TCR signal–enhancing mutation alters lipid metabolism of thymocytes and impairs antitumor immunity of mature T cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2507154122
Vancouver
Liang W, Liang Y, Yu M, Ji C, Wang F. TCR signal–enhancing mutation alters lipid metabolism of thymocytes and impairs antitumor immunity of mature T cells. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2507154122
BibTeX
@article{Liang2025,
author = {Liang, Wenhua and Liang, Yuge and Yu, Mingzhu and Ji, Chenshuang and Wang, Feng},
title = {TCR signal–enhancing mutation alters lipid metabolism of thymocytes and impairs antitumor immunity of mature T cells},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2507154122}
}
EUVIMED